Home / Cancer and immune system / Decitabine
ATC L01BC08 · Pyrimidine Analogues · updated 2 Nov 2026
Decitabine shortage
As of 2 Nov 2026, Decitabine has a reported shortage in 1 of the 16 countries we track (United States), covering 2 products from 1 company.
Is there a Decitabine shortage?
Yes. As of 2 Nov 2026, Decitabine is reported short in 1 of the 16 countries we track: United States. No company has given a return date.
Timeline
Solid bars run from the reported start to today; faded bars show the time left until the expected return. An arrow means no return date was given.
Which companies are short
products short, all countriesCompared with similar medicines
ATC group L01BC · Pyrimidine AnaloguesAffected products
| Country | Product | Company | Since | Expected back | Reason |
|---|---|---|---|---|---|
| US | Decitabine, Injection, 50 mg (NDC 50742-430-01) discontinuation | Ingenus Pharmaceuticals LLC | 20 Feb 2026 | not given | Not stated |
| US | Decitabine, Injection, 50 mg (NDC 68001-573-41) discontinuation | Ingenus Pharmaceuticals LLC | 20 Feb 2026 | not given | Not stated |
"Expected back" is the date the company gave the authority, when it gave one. Ask a pharmacist about alternatives.
Questions
Is there a Decitabine shortage?
Yes. As of 2 Nov 2026, Decitabine is reported short in 1 of the 16 countries we track: United States. No company has given a return date.
When will Decitabine be back in stock?
No return date has been given; United States: no date given. These are company estimates reported to each authority.
Why is Decitabine in short supply?
The most common reason reported is: not stated. Reasons by product are listed in the table below.
Which companies have Decitabine shortages?
Ingenus.